Biocon to enter derma and skincare segment

Must Read

Biocon Ltd, a leading biotechnology company, is all set to launch its derma and skincare portfolio as it seeks to expand the range of therapeutic segments in which it offers products. “The first product will be an ointment with immunosuppressants. We will have a tacrolimus ointment to begin with, but we will eventually offer a large portfolio. This will be hopefully a frontrunner to launch our psoriasis treatment after it successfully completes all trials,” says Kiran Mazumdar Shaw, Chairman and Managing Director, Biocon India. Biocon has a significant presence in four therapeutic segments — diabetology, oncology, nephrology and cardiology.


Latest News

Fashion brand icons: Darpan Kapoor of Kapsons Group

IndiaRetailing brings you a series in which we highlight the brand icons in India’s thriving fashion and lifestyle industry....

Login to your account below

Fill the forms bellow to register

Retrieve your password

Please enter your username or email address to reset your password.